🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Geena Mathew

National Institute of Technology Calicut

ORCID: 0000-0002-0764-5608

Also affiliated with The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplemental Tables from Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/2326-6066.22544087.v1
Top 100%
0DataRank
Top 100%0 citations

Molly B. El, Erica J. Lynn, Julianna Bronk, Tatiana V. Karpinets, Xiaogang Wu +40 more

Papers

Driven by 8 papers — median percentile 0. Top paper: “Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial”.

Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial

The Lancet Oncology(2023)10.1016/s1470-2045(23)00478-3
N/A
0.960DataRank · unranked
34 citations

Jessica M. Frakes, Todd A. Aguilera, Manisha Palta, Brian G. Czito, Manoop S. Bhutani +26 more

Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers

Cancer Immunology Research(2022)10.1158/2326-6066.cir-21-0119
N/A
0DataRank · unranked
14 citations

Molly B. El, Erica J. Lynn, Julianna Bronk, Tatiana V. Karpinets, Xiaogang Wu +40 more

Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring

Cancer Cell(2023)10.1016/j.ccell.2023.09.012
N/A
0DataRank · unranked
245 citations

Molly B. El Alam, Rui Wang, Tatiana V. Karpinets, David Lo, Erica J. Lynn +40 more

Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy

Brachytherapy(2023)10.1016/j.brachy.2023.10.007
N/A
0DataRank · unranked
1 citations

Molly B. El Alam, Erica J. Lynn, Tatiana V. Karpinets, Timothy Harris, David Lo +19 more

Data from Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers

(2023)10.1158/2326-6066.c.6550526
N/A
0DataRank · unranked
0 citations

Molly B. El, Erica J. Lynn, Julianna Bronk, Tatiana V. Karpinets, Xiaogang Wu +40 more

Supplemental Tables from Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/2326-6066.22544087.v1
Top 100%
0DataRank
Top 100%0 citations

Molly B. El, Erica J. Lynn, Julianna Bronk, Tatiana V. Karpinets, Xiaogang Wu +40 more

Candidate HPV-Specific T-Cells Expand in the Tumor Microenvironment During Chemoradiotherapy

Research Square(2021)10.21203/rs.3.rs-105933/v1
N/A
0DataRank · unranked
0 citations

Molly B. El Alam, Erica J. Lynn, Julianna K. Edwards, Tatiana V. Karpinets, Xiaogang Wu +39 more

Iterative intraoperative 3T MRI (iMRI)-guided brachytherapy: A prospective study on enhancing implantation precision and dosimetric gains in advanced gynecologic cancers

Brachytherapy(2025)10.1016/j.brachy.2025.06.010
N/A
0DataRank · unranked
1 citations

Matthew S. Ning, Megan Jacobson, Samantha J. Simiele, Teresa L. Bruno, Ramez Kouzy +16 more